Germany to allow use of psilocybin for drug-resistant depression

Germany has become the first country in the European Union to authorize the compassionate use of psilocybin for treatment-resistant depression, and the therapy will be delivered using Filament Health’s botanical psilocybin drug candidate, PEX010.